-
1
-
-
0345167930
-
Delayed-onset hypothesis of antipsychotic action: A hypothesis tested and rejected
-
Agid O, Kapur S, Arenovich T, et al. Delayed-onset hypothesis of antipsychotic action: A hypothesis tested and rejected. Arch Gen Psychiatry. 2003 ; 60: 1228-1235
-
(2003)
Arch Gen Psychiatry
, vol.60
, pp. 1228-1235
-
-
Agid, O.1
Kapur, S.2
Arenovich, T.3
-
2
-
-
46249123414
-
Early onset of antipsychotic response in the treatment of acutely agitated patients with psychotic disorders
-
Agid O, Kapur S, Warrington L, et al. Early onset of antipsychotic response in the treatment of acutely agitated patients with psychotic disorders. Schizophr Res. 2008 ; 102: 241-248
-
(2008)
Schizophr Res
, vol.102
, pp. 241-248
-
-
Agid, O.1
Kapur, S.2
Warrington, L.3
-
3
-
-
84864348832
-
Placebo-related effects in clinical trials in schizophrenia: What is driving this phenomenon and what can be done to minimize it?
-
Alphs L, Benedetti F, Fleischhacker WW, et al. Placebo-related effects in clinical trials in schizophrenia: What is driving this phenomenon and what can be done to minimize it?. Int J Neuropsychopharmacol. 2012 ; 15: 1003-1014
-
(2012)
Int J Neuropsychopharmacol
, vol.15
, pp. 1003-1014
-
-
Alphs, L.1
Benedetti, F.2
Fleischhacker, W.W.3
-
4
-
-
84870469320
-
-
4th edn. text revision (DSM-IV-TR). Washington, DC; American Psychiatric Publishing Inc.
-
Diagnostic and Statistical Manual of Mental Disorders. 2000 ) Diagnostic and Statistical Manual of Mental Disorders. 4th edn. text revision (DSM-IV-TR). Washington, DC; American Psychiatric Publishing Inc. Washington, DC: American Psychiatric Publishing Inc ; 2000 :
-
(2000)
Diagnostic and Statistical Manual of Mental Disorders
-
-
-
5
-
-
14844334624
-
Remission in schizophrenia: Proposed criteria and rationale for consensus
-
Andreasen NC, Carpenter WT, Kane JM, et al. Remission in schizophrenia: Proposed criteria and rationale for consensus. Am J Psychiatry. 2005 ; 162: 441-449
-
(2005)
Am J Psychiatry
, vol.162
, pp. 441-449
-
-
Andreasen, N.C.1
Carpenter, W.T.2
Kane, J.M.3
-
6
-
-
54249144638
-
Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia
-
Ascher-Svanum H, Nyhuis AW, et al. Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia. Schizophr Bull. 2008 ; 34: 1163-1171
-
(2008)
Schizophr Bull
, vol.34
, pp. 1163-1171
-
-
Ascher-Svanum, H.1
Nyhuis, A.W.2
-
7
-
-
0023630984
-
Predicting outcome of neuroleptic treatment on the basis of subjective response and early clinical improvement
-
Bartkó G, Herczeg I, Békésy M. Predicting outcome of neuroleptic treatment on the basis of subjective response and early clinical improvement. J Clin Psychiatry. 1987 ; 48: 363-365
-
(1987)
J Clin Psychiatry
, vol.48
, pp. 363-365
-
-
Bartkó, G.1
Herczeg, I.2
Békésy, M.3
-
8
-
-
33751116815
-
Optimizing early prediction for antipsychotic response in schizophrenia
-
Chang YC, Lane HY, Yang KH, et al. Optimizing early prediction for antipsychotic response in schizophrenia. J Clin Psychopharmacol. 2006 ; 26: 554-559
-
(2006)
J Clin Psychopharmacol
, vol.26
, pp. 554-559
-
-
Chang, Y.C.1
Lane, H.Y.2
Yang, K.H.3
-
9
-
-
1842435000
-
Early prediction of antipsychotic response in schizophrenia
-
Correll CU, Malhotra AK, Kaushik S, et al. Early prediction of antipsychotic response in schizophrenia. Am J Psychiatry. 2003 ; 160: 2063-2065
-
(2003)
Am J Psychiatry
, vol.160
, pp. 2063-2065
-
-
Correll, C.U.1
Malhotra, A.K.2
Kaushik, S.3
-
10
-
-
33644698983
-
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: Acute treatment of schizophrenia
-
Falkai P, Wobrock T, Lieberman J, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: Acute treatment of schizophrenia. World J Biol Psychiatry. 2005 ; 6: 132-191
-
(2005)
World J Biol Psychiatry
, vol.6
, pp. 132-191
-
-
Falkai, P.1
Wobrock, T.2
Lieberman, J.3
-
12
-
-
79955474605
-
Difference in early prediction of antipsychotic non-response between risperidone and olanzapine in the treatment of acute-phase schizophrenia
-
Hatta K, Otachi T, Sudo Y, et al. Difference in early prediction of antipsychotic non-response between risperidone and olanzapine in the treatment of acute-phase schizophrenia. Schizophr Res. 2011 ; 128: 127-135
-
(2011)
Schizophr Res
, vol.128
, pp. 127-135
-
-
Hatta, K.1
Otachi, T.2
Sudo, Y.3
-
13
-
-
0033680720
-
Selection bias in clinical trials with antipsychotics
-
Hofer A, Hummer M, Huber R, et al. Selection bias in clinical trials with antipsychotics. J Clin Psychopharmacol. 2000 ; 20: 699-702
-
(2000)
J Clin Psychopharmacol
, vol.20
, pp. 699-702
-
-
Hofer, A.1
Hummer, M.2
Huber, R.3
-
14
-
-
70649094031
-
Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic study
-
Jäger M, Schmauss M, Laux G, et al. Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic study. Eur Psychiatry. 2009 ; 24: 501-506
-
(2009)
Eur Psychiatry
, vol.24
, pp. 501-506
-
-
Jäger, M.1
Schmauss, M.2
Laux, G.3
-
15
-
-
77952154800
-
Efficacy and safety of asenapine in a placebo- and haloperidol-controlled trial in patients with acute exacerbation of schizophrenia
-
Kane JM, Cohen M, Zhao J, et al. Efficacy and safety of asenapine in a placebo- and haloperidol-controlled trial in patients with acute exacerbation of schizophrenia. J Clin Psychopharmacol. 2010 ; 30: 106-115
-
(2010)
J Clin Psychopharmacol
, vol.30
, pp. 106-115
-
-
Kane, J.M.1
Cohen, M.2
Zhao, J.3
-
16
-
-
18744412165
-
Evidence for onset of antipsychotic effects within the first 24 hours of treatment
-
Kapur S, Arenovich T, Agid O, et al. Evidence for onset of antipsychotic effects within the first 24 hours of treatment. Am J Psychiatry. 2005 ; 162: 939-946
-
(2005)
Am J Psychiatry
, vol.162
, pp. 939-946
-
-
Kapur, S.1
Arenovich, T.2
Agid, O.3
-
17
-
-
0023606101
-
The positive and negative syndrome scale (PANSS) for schizophrenia
-
Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987 ; 13: 261-276
-
(1987)
Schizophr Bull
, vol.13
, pp. 261-276
-
-
Kay, S.R.1
Fiszbein, A.2
Opler, L.A.3
-
18
-
-
28544441669
-
Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: A meta-analysis
-
Kemmler G, Hummer M, Widschwendter C, et al. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: A meta-analysis. Arch Gen Psychiatry. 2005 ; 62: 1305-1312
-
(2005)
Arch Gen Psychiatry
, vol.62
, pp. 1305-1312
-
-
Kemmler, G.1
Hummer, M.2
Widschwendter, C.3
-
19
-
-
46249092841
-
Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia
-
Kinon BJ, Chen L, Ascher-Svanum H, et al. Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia. Schizophr Res. 2008 ; 102: 230-240
-
(2008)
Schizophr Res
, vol.102
, pp. 230-240
-
-
Kinon, B.J.1
Chen, L.2
Ascher-Svanum, H.3
-
20
-
-
72449167382
-
Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia
-
Kinon BJ, Chen L, Ascher-Svanum H, et al. Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia. Neuropsychopharmacology. 2010 ; 35: 581-590
-
(2010)
Neuropsychopharmacology
, vol.35
, pp. 581-590
-
-
Kinon, B.J.1
Chen, L.2
Ascher-Svanum, H.3
-
21
-
-
70450260607
-
Early- and delayed antipsychotic response and prediction of outcome in 528 severely impaired patients with schizophrenia treated with amisulpride
-
Lambert M, Schimmelmann BG, Naber D, et al. Early- and delayed antipsychotic response and prediction of outcome in 528 severely impaired patients with schizophrenia treated with amisulpride. Pharmacopsychiatry. 2009 ; 42: 277-283
-
(2009)
Pharmacopsychiatry
, vol.42
, pp. 277-283
-
-
Lambert, M.1
Schimmelmann, B.G.2
Naber, D.3
-
22
-
-
77957844776
-
What's next after 50 years of psychiatric drug development: An FDA perspective
-
Laughren TP. What's next after 50 years of psychiatric drug development: An FDA perspective. J Clin Psychiatry. 2010 ; 71: 1196-1204
-
(2010)
J Clin Psychiatry
, vol.71
, pp. 1196-1204
-
-
Laughren, T.P.1
-
23
-
-
62849099049
-
How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials
-
Leucht S, Arbter D, Engel RR, et al. How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials. Mol Psychiatry. 2009a ; 14: 429-447
-
(2009)
Mol Psychiatry
, vol.14
, pp. 429-447
-
-
Leucht, S.1
Arbter, D.2
Engel, R.R.3
-
24
-
-
20444369114
-
Early-onset hypothesis of antipsychotic drug action: A hypothesis tested, confirmed and extended
-
Leucht S, Busch R, Hamann J, et al. Early-onset hypothesis of antipsychotic drug action: A hypothesis tested, confirmed and extended. Biol Psychiatry. 2005a ; 57: 1543-1549
-
(2005)
Biol Psychiatry
, vol.57
, pp. 1543-1549
-
-
Leucht, S.1
Busch, R.2
Hamann, J.3
-
25
-
-
33947729638
-
Early prediction of antipsychotic nonresposne among patients with schizophrenia
-
Leucht S, Busch R, Kissling W, et al. Early prediction of antipsychotic nonresposne among patients with schizophrenia. J Clin Psychiatry. 2007a ; 68: 353-360
-
(2007)
J Clin Psychiatry
, vol.68
, pp. 353-360
-
-
Leucht, S.1
Busch, R.2
Kissling, W.3
-
26
-
-
34547876496
-
Defining 'response' in antipsychotic drug trials: Recommendations for the use of scale-derived cutoffs
-
Leucht S, Davis JM, Engel RR, et al. Defining 'response' in antipsychotic drug trials: Recommendations for the use of scale-derived cutoffs. Neuropsychopharmacology. 2007b ; 32: 1903-1910
-
(2007)
Neuropsychopharmacology
, vol.32
, pp. 1903-1910
-
-
Leucht, S.1
Davis, J.M.2
Engel, R.R.3
-
27
-
-
64349118890
-
Definitions of response and remission in schizophrenia: Recommendations for their use and their presentation
-
Leucht S, Davis JM, Engel RR, et al. Definitions of response and remission in schizophrenia: Recommendations for their use and their presentation. Acta Psychiatr Scand Suppl. 2009b ; 438: 7-14
-
(2009)
Acta Psychiatr Scand Suppl
, vol.438
, pp. 7-14
-
-
Leucht, S.1
Davis, J.M.2
Engel, R.R.3
-
28
-
-
33748771190
-
Linking the PANSS, BPRS, and CGI: Clinical implications
-
Leucht S, Kane JM, Etschel E, et al. Linking the PANSS, BPRS, and CGI: Clinical implications. Neuropsychopharmacology. 2006 ; 31: 2318-2325
-
(2006)
Neuropsychopharmacology
, vol.31
, pp. 2318-2325
-
-
Leucht, S.1
Kane, J.M.2
Etschel, E.3
-
30
-
-
42749091544
-
Predicting antipsychotic drug response - Replication and extension to six weeks in an international olanzapine study
-
Leucht S, Shamsi SA, Busch R, et al. Predicting antipsychotic drug response - replication and extension to six weeks in an international olanzapine study. Schizophr Res. 2008 ; 101: 312-319
-
(2008)
Schizophr Res
, vol.101
, pp. 312-319
-
-
Leucht, S.1
Shamsi, S.A.2
Busch, R.3
-
31
-
-
36849032267
-
Extrapolation between measures of symptom severity and change: An examination of the PANSS and CGI
-
Levine SZ, Rabinowitz J, Engel R, et al. Extrapolation between measures of symptom severity and change: An examination of the PANSS and CGI. Schizophr Res. 2008 ; 98: 318-322
-
(2008)
Schizophr Res
, vol.98
, pp. 318-322
-
-
Levine, S.Z.1
Rabinowitz, J.2
Engel, R.3
-
32
-
-
35948929805
-
Early prediction of clinical response in schizophrenia patients receiving the atypical antipsychotic zotepine
-
Lin CH, Chou LS, Lin CH, et al. Early prediction of clinical response in schizophrenia patients receiving the atypical antipsychotic zotepine. J Clin Psychiatry. 2007 ; 68: 1522-1527
-
(2007)
J Clin Psychiatry
, vol.68
, pp. 1522-1527
-
-
Lin, C.H.1
Chou, L.S.2
Lin, C.H.3
-
33
-
-
30044439100
-
Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: A pooled post-hoc analysis of four atypical antipsychotic drugs
-
Liu-Seifert H, Adams DH, Kinon BJ. Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: A pooled post-hoc analysis of four atypical antipsychotic drugs. BMC Med. 2005 ; 3: 21
-
(2005)
BMC Med
, vol.3
, pp. 21
-
-
Liu-Seifert, H.1
Adams, D.H.2
Kinon, B.J.3
-
34
-
-
0021074155
-
The prediction of acute response, remission and general outcome of neuroleptic treatment in acute schizophrenic patients
-
Nedopil N, Pflieger R, Rüther E. The prediction of acute response, remission and general outcome of neuroleptic treatment in acute schizophrenic patients. Pharmacopsychiatria. 1983 ; 16: 201-205
-
(1983)
Pharmacopsychiatria
, vol.16
, pp. 201-205
-
-
Nedopil, N.1
Pflieger, R.2
Rüther, E.3
-
36
-
-
35948982974
-
Efficacy and tolerability of asenapine in acute schizophrenia: A placebo- and risperidone-controlled trial
-
Potkin SG, Cohen M, Panagides J. Efficacy and tolerability of asenapine in acute schizophrenia: A placebo- and risperidone-controlled trial. J Clin Psychiatry. 2007 ; 68: 1492-1500
-
(2007)
J Clin Psychiatry
, vol.68
, pp. 1492-1500
-
-
Potkin, S.G.1
Cohen, M.2
Panagides, J.3
-
37
-
-
17644371975
-
How representative of everyday clinical populations are schizophrenia patients enrolled in clinical trials?
-
Riedel M, Strassnig M, Müller N, et al. How representative of everyday clinical populations are schizophrenia patients enrolled in clinical trials?. Eur Arch Psychiatry Clin Neurosci. 2005 ; 255: 143-148
-
(2005)
Eur Arch Psychiatry Clin Neurosci
, vol.255
, pp. 143-148
-
-
Riedel, M.1
Strassnig, M.2
Müller, N.3
-
38
-
-
79651470675
-
Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia
-
Ruberg SJ, Chen L, Stauffer V, et al. Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia. BMC Psychiatry. 2011 ; 11: 23
-
(2011)
BMC Psychiatry
, vol.11
, pp. 23
-
-
Ruberg, S.J.1
Chen, L.2
Stauffer, V.3
-
39
-
-
78649388138
-
Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic study
-
Schennach-Wolff R, Obermeier M, Seemüller F, et al. Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic study. J Clin Psychopharmacol. 2010 ; 30: 726-731
-
(2010)
J Clin Psychopharmacol
, vol.30
, pp. 726-731
-
-
Schennach-Wolff, R.1
Obermeier, M.2
Seemüller, F.3
-
40
-
-
79953079202
-
Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis
-
Stauffer V, Case M, Kinon BJ, et al. Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis. Psychiatry Res. 2011 ; 187: 42-48
-
(2011)
Psychiatry Res
, vol.187
, pp. 42-48
-
-
Stauffer, V.1
Case, M.2
Kinon, B.J.3
-
41
-
-
0027194208
-
Early response to haloperidol treatment in chronic schizophrenia
-
Stern RG, Kahn RS, Harvey PD, et al. Early response to haloperidol treatment in chronic schizophrenia. Schizophr Res. 1993 ; 10: 165-171
-
(1993)
Schizophr Res
, vol.10
, pp. 165-171
-
-
Stern, R.G.1
Kahn, R.S.2
Harvey, P.D.3
|